138 results
Page 3 of 7
S-8
nkin fusxb2
30 Jun 21
Registration of securities for employees
4:02pm
S-8
EX-5.1
gz4evwxgryz7i 9r3eum
30 Jun 21
Registration of securities for employees
4:02pm
S-8
EX-23.1
jmo3zdirwt1u7kh6tpf
30 Jun 21
Registration of securities for employees
4:02pm
8-K
EX-10.1
f2yoni1c154iwloque
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
8-K
nigjvcs pl9utkh4
10 Jun 21
Submission of Matters to a Vote of Security Holders
5:30pm
424B3
2z7 il7q3ar
12 Apr 21
Prospectus supplement
1:44pm
S-3
69dljw6i84rgmv1b5ml
2 Apr 21
Shelf registration
12:00am
S-3
EX-5.1
kqqwa 8mfg8
2 Apr 21
Shelf registration
12:00am
S-3
EX-23.1
ig41tdp3sdh1dyd1
2 Apr 21
Shelf registration
12:00am
8-K
EX-10.1
omja4
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-10.2
qbbn5bsy 43txun2yg
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
jr9wmczow7nvdacv2
5 Nov 20
Processa Pharmaceuticals Announces the Appointment of
9:00am
8-K
EX-1.1
e48dezy285 rv1xkd3z
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm